Excess Opioid Disposal Following Orthopedic Foot and Ankle Surgery
- Conditions
- Medication DisposalBehavior
- Interventions
- Device: Deterra Drug Deactivation System
- Registration Number
- NCT03285061
- Lead Sponsor
- Brigham and Women's Hospital
- Brief Summary
This study aims to survey the drug disposal methods of orthopedic foot and ankle patients with excess pain medication following and operation. The study is a randomized control trial comparing the use of FDA approved at home disposal methods to current clinical methods of recommending disposal at medication drop off locations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 75
- This study will include foot and ankle orthopedic patients at Brigham and Women's Hospital undergoing a surgical procedure.
- Those under age 18 will be excluded from this study, as their variation in care could affect the data. We will also exclude adults with impaired decision-making capacity and adults who take methadone or have a history of prior opioid dependence.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description At Home Disposal Deterra Drug Deactivation System With patients' prescription for post operative pain medication, a Deterra portable drug deactivation system will be provided, along with instructions on proper use. They will be asked complete a survey at their 6 post operative follow-up on excess medication disposal.
- Primary Outcome Measures
Name Time Method Number of Participants Who Safely Disposed The Excess Medication 6 weeks Patients will be given a survey to obtain their method of disposal for excess post-operative pain medication.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Brigham and Women's Hospital
🇺🇸Boston, Massachusetts, United States